We’re proud to announce an exciting new partnership between Dr. Brad Herbst, board-certified podiatrist based on San Jose Boulevard, and Symphony Research, a leading clinical research company dedicated to innovation in medicine.
This collaboration brings groundbreaking opportunities to our patients—specifically those suffering from chronic, hard-to-heal foot and leg wounds. Through carefully selected clinical studies, eligible patients will now have access to advanced, FDA-approved treatments designed to promote faster healing and improved outcomes.
Here’s what this means for our patients:
- Complimentary Wound Care: Participants in the research studies will receive cutting-edge treatments at no cost.
- Reimbursement for Time and Travel: Your participation matters—and we want to make it convenient for you to contribute to the future of wound care.
- A Role in Medical Advancement: By joining these studies, patients become part of a greater mission—helping researchers and physicians develop more effective treatments for others facing similar challenges.
“Wound care is a complex and evolving field,” says Dr. Herbst. “This partnership allows us to go beyond traditional treatment and give our patients access to emerging therapies that may not be widely available yet—but are backed by science and regulated for safety.”
Whether you’re currently managing a chronic wound or know someone who is, we encourage you to reach out and learn more about these clinical study opportunities. With expert care and support from our team and Symphony Research, you can take a step toward healing—while making a lasting impact on the future of podiatric medicine.
To find out if you’re eligible, contact our San Jose Boulevard office at 904-268-6993. Together, we’re not just treating wounds—we’re transforming care.